
Sign up to save your podcasts
Or


In the first of a two part-series, Anthony and Bernie dive into the data surrounding maintenance therapies in AML. This episode focuses on maintenance therapy for patients ineligible for transplant, with a focus on oral azacitidine and the controversial QUAZAR study.
Key References:
By Bernard Marini, Anthony Perissinotti, et al.4.5
3030 ratings
In the first of a two part-series, Anthony and Bernie dive into the data surrounding maintenance therapies in AML. This episode focuses on maintenance therapy for patients ineligible for transplant, with a focus on oral azacitidine and the controversial QUAZAR study.
Key References:

38,062 Listeners

25,797 Listeners

87,529 Listeners

111,948 Listeners

56,508 Listeners

188 Listeners

10,282 Listeners

7,230 Listeners

51 Listeners

8 Listeners

15,950 Listeners

10,745 Listeners

51 Listeners

195 Listeners

736 Listeners